Grant directory

Open

Funds small multidisciplinary teams applying bioengineering to a specific biomedical, translational or clinical problem, up to $500,000.

Open

Funds microelectronics teams in the United States through CHIPS BAA with practical support for near market technology development.

Open

Funds an institution in a historically low-NIH-funding state to build a whole new biomedical research center in one area, from scratch.

Open

Funds expanding or sustaining an existing biomedical research center, capped by how many such centers an institution already holds.

Open

Provides innovation-focused loans for Lithuanian firms pursuing research development and pilot commercialization with supportive repayment terms.

Open

Funds running an investigator-initiated, milestone-driven clinical trial that needs closer NIH oversight, including any mechanistic sub-studies.

Open

Funds two or more linked infectious-disease or immunology research projects under one shared program grant, with a common theme.

Open

Funds a shared resource — a repository, tool or facility — for NIAID-funded immunology and infectious disease research, built only when nothing else fits.

Open

Funds a US-led international research collaboration by pairing a domestic award with an independent, linked award to the foreign partner.

Open

Funds Indian companies and startups scaling RDI-intensive technologies through concessional loans and equity.

Open

Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.

Open

Funds United States health initiatives through topic-focused pathways across multiple mission areas and agencies.

Open

Funds United States small businesses validating high-risk defense science concepts for practical technical development.

Open

Supports United States defense innovators building on validated concepts into advanced prototypes and field testing.

Open

Funds young Finnish deep-tech companies commercialising research results through a phased grant-and-loan package.

Open

Funds U.S. small businesses and their nonprofit research partners to conduct feasibility studies on translational science innovations toward commercialization.

Open

Funds U.S. small businesses and their nonprofit research partners to continue and expand translational R&D begun in STTR Phase I toward a commercial product.

Open

Provides Canadian innovators with hands-on guidance for technology-led projects and commercialization planning.

Open

Administers late-stage medical countermeasure development with United States government procurement pathways for strategic stockpile readiness.

Open

Funds Italian companies in southern regions to develop critical innovation in climate, health, and materials.

Open

Funds companies moving ENEA laboratory technologies toward industrial use through co-funded proof-of-concept projects.

Open

Funds companies and freelancers in Germany delivering digitalization projects with subsidized loans and grants up to €200,000.

Open

Funds SMEs maturing and testing technology projects with grants of up to EUR 50,000.

Open

Funds French companies carrying out high-growth R&D projects with regional grants or recoverable advances.